MPS Pharmaa Limited (BOM:531686)
India flag India · Delayed Price · Currency is INR
1.810
0.00 (0.00%)
At close: Jun 15, 2026

MPS Pharmaa Statistics

Total Valuation

MPS Pharmaa has a market cap or net worth of INR 34.59 million. The enterprise value is 109.82 million.

Market Cap34.59M
Enterprise Value 109.82M

Important Dates

The last earnings date was Thursday, May 28, 2026.

Earnings Date May 28, 2026
Ex-Dividend Date n/a

Share Statistics

MPS Pharmaa has 19.11 million shares outstanding. The number of shares has increased by 0.70% in one year.

Current Share Class 19.11M
Shares Outstanding 19.11M
Shares Change (YoY) +0.70%
Shares Change (QoQ) +3.01%
Owned by Insiders (%) 21.72%
Owned by Institutions (%) 1.06%
Float 5.71M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 97.17
PB Ratio 50.50
P/TBV Ratio 50.50
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.23, with a Debt / Equity ratio of 109.84.

Current Ratio 0.23
Quick Ratio 0.00
Debt / Equity 109.84
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,129.25

Financial Efficiency

Return on equity (ROE) is -177.51% and return on invested capital (ROIC) is -7.00%.

Return on Equity (ROE) -177.51%
Return on Assets (ROA) -6.34%
Return on Invested Capital (ROIC) -7.00%
Return on Capital Employed (ROCE) -310.45%
Weighted Average Cost of Capital (WACC) 1.29%
Revenue Per Employee 19,778
Profits Per Employee -566,667
Employee Count18
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax -379,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.42% in the last 52 weeks. The beta is -0.03, so MPS Pharmaa's price volatility has been lower than the market average.

Beta (5Y) -0.03
52-Week Price Change -34.42%
50-Day Moving Average 2.15
200-Day Moving Average 2.50
Relative Strength Index (RSI) 43.57
Average Volume (20 Days) 10,083

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, MPS Pharmaa had revenue of INR 356,000 and -10.20 million in losses. Loss per share was -0.53.

Revenue356,000
Gross Profit 356,000
Operating Income -9.03M
Pretax Income -10.58M
Net Income -10.20M
EBITDA -7.57M
EBIT -9.03M
Loss Per Share -0.53
Full Income Statement

Balance Sheet

The company has 13,000 in cash and 75.24 million in debt, with a net cash position of -75.23 million or -3.94 per share.

Cash & Cash Equivalents 13,000
Total Debt 75.24M
Net Cash -75.23M
Net Cash Per Share -3.94
Equity (Book Value) 685,000
Book Value Per Share 0.04
Working Capital -63.22M
Full Balance Sheet

Cash Flow

Operating Cash Flow -5.90M
Capital Expenditures n/a
Depreciation & Amortization 1.47M
Net Borrowing 661,000
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -2,537.64%
Pretax Margin -2,971.63%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MPS Pharmaa does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.70%
Shareholder Yield -0.70%
Earnings Yield -29.49%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2